-
DE
Alirocumab is a cholesterol-lowering medication belonging to the PCSK9 inhibitor class. It is used when conventional therapies are insufficient to control LDL levels.
Regular tips about health Regular tips about health Add as Preferred SourceAlirocumab is a cholesterol-lowering medication belonging to the PCSK9 inhibitor class. It is used when conventional therapies are insufficient to control LDL levels.
Alirocumab is a biotechnology-derived monoclonal antibody belonging to the class of PCSK9 inhibitors. It is marketed under the brand name Praluent and is indicated for lowering elevated LDL cholesterol levels in the blood. The medication is administered by subcutaneous injection and is approved for use in adults with specific lipid disorders.
Alirocumab is indicated for:
Alirocumab inhibits the enzyme PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9). Under normal conditions, PCSK9 binds to LDL receptors on the surface of liver cells and promotes their degradation. By blocking PCSK9, more LDL receptors remain available to remove LDL cholesterol from the bloodstream. This leads to a significant reduction in LDL cholesterol levels – by up to 60% compared to placebo in clinical trials.
Alirocumab is administered as a subcutaneous injection, typically every two weeks. It is available as a prefilled pen or prefilled syringe. The standard dose is 75 mg every two weeks, which may be increased to 150 mg if the response is insufficient. A 300 mg dose for monthly administration is also approved. Patients can self-administer the injection after appropriate training.
Alirocumab is generally well tolerated. The most common side effects include:
Rarer but potentially more serious side effects include allergic reactions and possible neurocognitive effects that were observed in some studies, the clinical significance of which is still being investigated.
Alirocumab is frequently used as an add-on to statin therapy or as an alternative in cases of statin intolerance. The landmark ODYSSEY OUTCOMES trial demonstrated that alirocumab significantly reduces the risk of myocardial infarction, stroke, and cardiovascular death in patients following acute coronary syndrome. It therefore represents an important component of modern lipid-lowering therapy in high-risk patients.
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Average rating of 4.97 out of 5 stars
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
Average rating of 4.85 out of 5 stars
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
Average rating of 4.87 out of 5 stars
Daily basic supply: the complete spectrum of micronutrients
Natural multivitamin complex for the immune system, energy, and central body functions
Average rating of 4.94 out of 5 stars
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.